Is GRAIL, LLC (GRAL) overvalued? · rev $147.2M
GRAIL, LLC (GRAL) is a diagnostics & research company listed on US.
This page asks whether GRAIL, LLC (GRAL) looks expensive on cached numbers — not a short thesis.
Latest reported GRAL revenue for 2025-12-31 was $147.2M. Net income was -$408.4M. Revenue was up 17.2% from 2024-12-31 to 2025-12-31. GRAL currently screens at market cap $2.57B.
GRAL currently screens at market cap $2.57B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next GRAL 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the GRAL stock page for the full model, not this heading.
Not investment advice.